Figure 5From: Increased expression of CYP17A1 indicates an effective targeting of the androgen receptor axis in castration resistant prostate cancer (CRPC)Western Blot analysis of the AR and CYP17A1 after AA treatment with 5 μmol/L. In western blot analyses no significant changes were detected on the AR protein level (A), whereas CYP17A1 protein expression increased markedly (B).Back to article page